Welcome to LookChem.com Sign In|Join Free

CAS

  • or

129488-55-7

N-(4-AMINOPHENYL)-4-TERT-BUTYLBENZAMIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

129488-55-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 129488-55-7 Structure

  • Basic information

    1. Product Name: N-(4-AMINOPHENYL)-4-TERT-BUTYLBENZAMIDE
    2. Synonyms: AKOS BB-8144;ASISCHEM T31116;ART-CHEM-BB B025190;LABOTEST-BB LT00432136;N-(4-AMINOPHENYL)-4-TERT-BUTYLBENZAMIDE;TIMTEC-BB SBB001050
    3. CAS NO:129488-55-7
    4. Molecular Formula: C17H20N2O
    5. Molecular Weight: 268.35
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 129488-55-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: N-(4-AMINOPHENYL)-4-TERT-BUTYLBENZAMIDE(CAS DataBase Reference)
    10. NIST Chemistry Reference: N-(4-AMINOPHENYL)-4-TERT-BUTYLBENZAMIDE(129488-55-7)
    11. EPA Substance Registry System: N-(4-AMINOPHENYL)-4-TERT-BUTYLBENZAMIDE(129488-55-7)

  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 129488-55-7(Hazardous Substances Data)

129488-55-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 129488-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,4,8 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 129488-55:
(8*1)+(7*2)+(6*9)+(5*4)+(4*8)+(3*8)+(2*5)+(1*5)=167
167 % 10 = 7
So 129488-55-7 is a valid CAS Registry Number.

129488-55-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-aminophenyl)-4-tert-butylbenzamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:129488-55-7 SDS

129488-55-7Relevant articles and documents

Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments

Wang, Ru,Liu, Hu,You, Yuan-Yuan,Wang, Xin-Yu,Lv, Bing-Bing,Cao, Li-Qin,Xue, Jia-Yu,Xu, Yun-Gen,Shi, Lei

supporting information, (2021/02/02)

VEGF/VEGFR-2 signaling plays a critical part in tumor angiogenesis. Inhibition of this pathway has been considered as a promising approach for cancer treatment. In this work, a series of 6,7-dimethoxy-4-anilinoquinazoline derivatives bearing diarylamide moiety were designed, synthesized and evaluated as potent inhibitors of VEGFR-2 kinase. Their in vitro antiproliferation activities against two human cancer cell lines Hep-G2 and MCF-7 have also been determined. Among them, compound 14b exhibited the most potent inhibitory activity against VEGFR-2 with IC50 value of 0.016 ± 0.002 μM and it showed the most potent antiproliferative effect against Hep-G2 and MCF-7 with IC50 values at low-micromolar range. Molecular docking studies revealed that these compounds represented by the most potent compound 14b could bind well to the ATP-binding site of VEGFR-2, which suggested that compound 14b could be a potential anticancer agent targeting VEGFR-2.

INFLUENZA VIRUS INHIBITOR TARGETING NUCLEOPROTEIN

-

Paragraph 0102; 0105, (2019/06/09)

This document discloses a novel class of compound for treating influenza A and influenza B viral infection, and compositions and methods of use thereof.

Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein

White, Kris M.,Abreu, Pablo,Wang, Hui,De Jesus, Paul D.,Manicassamy, Balaji,García-Sastre, Adolfo,Chanda, Sumit K.,Devita, Robert J.,Shaw, Megan L.

, p. 146 - 157 (2018/02/14)

S119 was a top hit from an ultrahigh throughput screen performed to identify novel inhibitors of influenza virus replication. It showed a potent antiviral effect (50% inhibitory concentration, IC50 = 20 nM) and no detectable cytotoxicity (50% c

Pharmaceutical compositions containing phenylamides

-

, (2008/06/13)

Pharmaceutical compositions for inhibiting the aggregation of erthyrocytes or thrombocytes which include phenylamides which conform to the formula: STR1 with R1-6, X, A and B being as defined. Processes for the preparation of novel phenylamides

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 129488-55-7